The PI3K/Akt signaling pathway can be upregulated in gliomas through several mechanisms, most commonly through mutation or loss of heterozygosity of PTEN or through amplification/over-expression of critical growth factor receptors such as EGFR and PDGFR. Here, PTEN is linked to central nervous system cancer.